Abstract: M-CSF (or CSF-1) controls macrophage lineage development and function. A CSF-1-dependent culture system was established, which monitored the differentiation of CSF-1-responsive macrophage populations over time and upon adherence. Wiskott-Aldrich syndrome protein verprolin homologous (WAVE) proteins are involved in actin reorganization, a process critical to many cell functions. WAVE2 but not WAVE1 has been considered significant for macrophage function. Using the CSF-1-dependent differentiation system, we were able to demonstrate the contrasting regulation of the expression of WAVE1 and WAVE2; the levels of the latter rose over time and as the macrophage population became adherent, although those of the former increased over time but were down-regulated upon adherence. Evidence was obtained that WAVE1 was also cleaved to a novel, 60-kDa fragment by macrophage adherence and by another pathway involving calpain-mediated proteolysis. Mutagenesis studies indicated that cleavage of WAVE1 by calpain results in the removal of the verprolin-homology, cofilin-like, and acidic domain and thus, the loss of WAVE1 activity. We suggest that WAVE1 is also important for macrophage biology and that it could have separate functions to those of WAVE2. J. Leukoc. Biol. 84: 000 -000; 2008.
INTRODUCTION
In the adult, cells of the monocyte/macrophage lineage originate from the bone marrow and undergo differentiation from precursor cells to blood monocytes and finally, to tissue-specific macrophages. M-CSF (or CSF-1) is considered to be a primary regulator of macrophage development and function, as it has pleiotropic effects on macrophage lineage cells, regulating their survival, proliferation, differentiation, migration, and activation [1] [2] [3] [4] [5] . As direct in vivo evidence for this role, osteopetrotic (op/op) mice, which have a null mutation in the gene encoding CSF-1 [6, 7] , have a deficiency in a number of tissue macrophage populations, including osteoclasts [6, 8] .
Some macrophage functions, such as secretion, migration, and phagocytosis, require cytoskeletal remodeling [9 -11] . A number of GTPase-activating proteins (GAPs) and GAP-associated proteins are activated upon CSF-1 stimulation, as is a Rho family guanine nucleotide-exchange factor (GEF), Vav [12, 13] . GAPs and GEFs are important regulators of Rho GTPases, such as Rho, Rac, and Cdc42, all of which are involved in cytoskeletal-based processes such as adhesion and migration [4] . Adhesion of macrophage populations to a surface can also have a significant effect on their differentiation and activation [14 -16] .
Wiskott-Aldrich family verprolin-homologous protein 1 (WAVE1) and WAVE2 belong to the family of Wiskott-Aldrich syndrome proteins (WASPs), which also include WASP, N-WASP, and WAVE3, all of which play a part in actin reorganization and therefore, in processes such as cell motility, adhesion, and spreading [17] . The initiation of actin polymerization is thought to involve severing or uncapping of the barbed ends of actin filaments and de novo nucleation [17] . An important aspect of the latter step is the interaction between WASPs or WAVEs and the actin-related protein (Arp)2/3 complex [18] . Structurally, proteins of the WASP family consist of a WAVE homology domain (WHD), a basic region, a praline-rich region, and a verprolin-homology, cofilin-like, and acidic region (VCA) domain [17] . It is through the VCA domain that WASP and WAVE proteins bind to actin and the Arp2/3 complex to mediate actin nucleation, although other domains are thought to be involved in protein-protein interactions that regulate this process [19] .
WAVE1 activity has been presumed to be confined mainly to neural tissue, as its expression is highest in brain and detected at only low levels elsewhere. To date, few studies have focused on its function in the immune and hemopoietic systems. In platelets, WAVE1 is the most abundant isoform, although WAVE2 appears to play a greater role in the spreading of activated platelets [20] . There is some evidence for WAVE1 and WAVE2 regulating actin polymerization in response to T cell activation, particularly in the formation of the immunologic synapse; however, the relevant mechanisms are not understood, and it is not clear whether both isoforms are required [21] . In the myeloid cell line HL-60, WAVE1 gene expression was found to be down-regulated during PMA-induced differentiation [22] . In a study using bone marrowderived macrophages (BMM), WAVE2 was proposed to be involved in cell migration in response to CSF-1, and it appeared to be the only WAVE protein to be expressed at a significant level in macrophages [23] ; consequently, the role of WAVE1 has not been investigated in these cells.
Myosins are actin-based cellular motor proteins with roles in many forms of cellular motility such as phagocytosis and migration. Two isoforms of the unconventional myosin, MysPDZ or Myo18A, have been described with suggested, contrasting actions in macrophage differentiation [24] . We recently described a third isoform, p110 Myo18A, which seems to be a post-translational cleavage product of either or both of the higher molecular weight isoforms and is preferentially tyrosine-phosphorylated following CSF-1 action [25] .
We report here on the development of a CSF-1-dependent macrophage differentiation system and in which cell adherence was also found to modulate WAVE and Myo18A expression. Data are presented for the reciprocal regulation of the gene expression of WAVE1 and WAVE2 and also of Myo18A isoforms. Evidence is also provided for a novel, 60-kDa WAVE1 cleavage product, which can be generated in macrophages via calpain-dependent and calpain-independent mechanisms.
MATERIALS AND METHODS

Reagents and antibodies
Calcium ionomycin and calpain 1 were purchased from Sigma Chemical Co. (St. Louis, MO, USA) and calpeptin from Calbiochem (San Diego, CA, USA). For Western blot analysis, N-terminal and C-terminal anti-WAVE1 antibodies, as well as the anti-WAVE2 antibody that recognizes the N-terminal region, were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Other antibodies used were anti-myc (Cell Signaling Technologies, Danvers, MA, USA) and anti-GFP (Invitrogen, Grand Island, NY, USA), as well as HRP-conjugated anti-goat and anti-mouse Igs (DakoCytomation, Glostrup, Denmark). Antibodies used for flow cytometry were those for membrane-activated complex 1 (Mac-1), Ly6G, and B220 (BD PharMingen, San Diego, CA, USA), CSF-1R (derived from the ASF-98 hybridoma [26] , obtained from Dr. S-I. Nishikawa, Kyoto University, Japan), and F4/80 and isotype control antibodies (Caltag Laboratories, San Francisco, CA, USA).
Cell culture
BMM were obtained from precursor cells from 6-to 8-week-old male C57Bl/6 mice using an established method [27, 28] . Briefly, femoral bone marrow cells (denoted as Day 0 cells) were cultured in T175 tissue-culture flasks (BD Biosciences, Bedford, MA, USA) at 10 5 cells/ml in 50 ml for 4 days in RPMI (Invitrogen), supplemented with 10% FCS (CSL, Melbourne, Australia), 2 mM glutamate, penicillin (100 U/ml), 100 g/ml streptomycin sulfate (all from Invitrogen), and 5000 U/ml recombinant human CSF-1 (Chiron Corp., Emeryville, CA, USA). Nonadherent cells (d4NA) were harvested at 1 ϫ 10 6 cells/ml in 10 ml and cultured for an additional 2 days in 100 mm tissueculture dishes (BD Biosciences). The resultant Day 6 cells were then divided into nonadherent (d6NA) and adherent (BMM) populations.
The RAW264.7 murine macrophage cell line and the human embryonic kidney (HEK)293T cell line were maintained in DMEM (Invitrogen) with 10% FCS, penicillin (100 U/ml), 100 g/ml streptomycin sulfate, and 2 mM glutamate.
RNA extraction and quality control
Approximately 10 8 cells were harvested, and total RNA was extracted using the RNeasy Maxikit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RNA was eluted in 1.2 ml RNase-free water and where necessary, was precipitated with 0.1 vol 3 M sodium acetate (pH 5.2) and 2 vol 100% ethanol. RNA integrity was confirmed with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
RT-PCR
Total RNA (2 g) was reverse-transcribed using Superscript III RT (Invitrogen). The resulting cDNA solution was used directly in subsequent RT-PCR and quantitative PCR (qPCR) experiments. For RT-PCR, primers were manufactured by Geneworks (Adelaide, South Australia), and their sequences were as follows: CSF-1R forward: 5Ј-CTGTGAATGGCTCTGATGTCCTGTTCTG-3Ј, reverse: 5Ј-CTCCCACTTCTCATTGTAGGGCAACTGA-3Ј; scavenger receptor A (SR-A) forward: 5Ј-CCAAGTCCTTGCAGAGTCTG-3Ј, reverse: 5Ј-GTCT-GAGGTCGTTGGTGATG-3Ј; lysozyme forward: 5Ј-GACTCTGGGACTCCTC-CTGC-3Ј, reverse: 5Ј-GTTCGCCATGCCACCCATGC-3Ј; ferritin forward: 5Ј-CGCCAGAACTACCACCAGGAC-3Ј, reverse: 5Ј-GTTGGTCACGTGGTCAC-CCAG-3Ј; Mac-1 forward: 5Ј-ATTGAGGGCACGCAGACAGGAAGTA-3Ј, reverse: 5Ј-TAGTAATGAGGGGCCCCAATGAGGA-3Ј; GAPDH forward: 5Ј-GGCGATCTTGGGCTACACTG-3Ј, reverse: 5Ј-CCTTGGAGGCCATGTAG-GCC-3Ј. For qPCR, gene-specific, premixed probes and primers for WAVE1, WAVE2, and Myo18A variants 1 and 2 were obtained from Applied Biosystems (Foster City, CA, USA). PCR was performed using a 7900HT sequence detection system (Applied Biosystems).
Flow cytometry
Cells were collected at 10 5 cells/sample, and nonspecific binding was blocked with 10% mouse serum and 1% BSA in PBS. Cells were then incubated with antibodies to Mac-1, Ly-6G, B220, F4/80, and CSF-1R or isotype control antibodies. Detection of cell surface proteins was performed using a FACSCalibur (BD PharMingen) and analyzed with CellQuest (BD PharMingen).
Expression constructs
The N-terminal Myc-tagged WAVE1 (in pRK5) expression construct was kindly provided by Professor Laura Machesky (The University of Birmingham, Edgbaston, Birmingham, UK). The Myc-WAVE1-internal ribozyme entry site (IRES)-GFP expression construct was generated by PCR using the following primer pair: 5Ј-GCT AGC CACC ATG GAA CAA AAA CTC ATC TCA-3Ј (forward) and 5Ј-CTC GAG TTA CTC CAA CCA ATC TAC TTC ATC AAA-3Ј (reverse) and the pRK5-Myc-WAVE1 construct as the template. The PCR product generated was digested with NheI and XhoI (sites in the primers are underlined) and subcloned into plasmid IRES2 (pIRES2)-enhanced GFP (Clontech, Mountain View, CA, USA).
Mutagenesis was performed using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) following instructions from the manufacturer. The original pRK5-Myc-WAVE1 construct was used as the template. Two separate sites were targeted: Pro-399 to Ala-403, where the sequence PVARA was mutated to PGAGG, and Pro-457 to Ser-460, where the amino acids PTPS were mutated to GGPG. Sequencing of the mutated construct was performed prior to transfection.
Transfection
HEK293T cells were seeded into six-well plates at a density of 3.5 ϫ 10 5 cells per well. The next day, cells were transfected using FuGene 6 transfection reagent (Roche, Basel, Switzerland), according to protocols recommended by the manufacturer. Cells were analyzed by Western blot analysis 24 h posttransfection. RAW264.7 cells (at 5ϫ10 6 cells/ml) were electroporated with 10 g plasmid in a volume of 250 L cell culture media at 960 F and 280 mV in 0.4 cm Gene Pulser cuvettes (Bio-Rad, Hercules, CA, USA). Cells were reseeded in tissue-culture plates, and expression of the transfected construct was monitored by flow cytometry and/or Western blot analysis at indicated time-points.
Western blotting and immunoprecipitation assays
Cells (1ϫ10 7 ) were lysed in 1 ml lysis buffer [20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% (w/v) deoxycholate, 0.1% SDS, 10% glycerol, 1 mM sodium vanadate, 100 M molybdate, 10 mM ␤-glycerolphosphate, 10 mM sodium fluoride]. For a typical gel, 40 g protein aliquots of each sample were separated on 10% SDS-polyacrylamide gels (Invitrogen) and transferred to Immobilin-P membranes (Millipore, Bedford, MA, USA). Primary antibodies used for immunoblotting were anti-WAVE1 (N-terminal), anti-WAVE2, and anti-myc antibodies. HRP-conjugated anti-goat and antimouse Igs were used as secondary antibodies. Protein bands were visualized on X-ray film using the ECL system (Amersham, Piscataway, NJ, USA).
For immunoprecipitation, 1 mg cell protein was made up to a total volume of 1 ml and incubated with 1 g anti-WAVE1 antibody (C-terminal) for 3 h at 4°C, after which, 20 l Protein A Sepharose slurry (GE Healthcare, Uppsala, Sweden) was added, and samples were then incubated while mixing overnight at 4°C. The beads were then washed three times with lysis buffer and collected for in vitro calpain proteolysis.
In vitro calpain proteolysis assay
Immunoprecipitated WAVE1 was resuspended in 20 l calpain proteolysis buffer [40 mM HEPES (pH 7.2), 5 mM DTT, 1 mM CaCl 2 ] containing 5 units/ml calpain 1 and incubated at 37°C for indicated time-points. The negative control was without calpain and incubated for 60 min. The reaction was inactivated by the addition of reducing SDS-PAGE sample buffer and denaturation at 95°C for 5 min. The supernatant was then subjected to SDS-PAGE and Western blotting.
RESULTS
A CSF-1-dependent macrophage differentiation system BMM are generated in vitro as the adherent population arising from the proliferation and differentiation of murine bone marrow precursor cells after a few days in CSF-1 [27, 28] . The logic behind this protocol is that cells of other lineages are gradually depleted because of the CSF-1R-driven selection of CSF-1-responsive macrophage lineage precursors [27] . To generate precursors to monitor their differentiation into BMM, we harvested nonadherent cells following 4 days culture in CSF-1 (termed d4NA cells). As a macrophage differentiation system, the d4NA cells were then cultured in CSF-1 for a further 2 days to give rise to more mature, nonadherent cells (d6NA cells) and the adherent BMM; the adherent step is likely to induce changes, some of which at least may reflect further maturation.
At the morphologic level, d4NA cells were blast-like and small, the d6NA cells were slightly larger, more irregular in shape, and more vacuolated, and the BMM were larger again, extensively vacuolated, and had ruffled membranes (data not shown). Several macrophage lineage genes, such as the CSF-1R (or c-Fms), lysozyme, and Mac-1, were up-regulated along the differentiation sequence, along with SR-A, a surface molecule involved in adhesion and pathogen recognition and uptake [29] , and also ferritin, an iron transport protein that has been shown to be up-regulated during macrophage differentiation [30, 31] (Fig. 1) . By flow cytometry, the percentage of cells expressing macrophage lineage markers (CSF-1R, Mac-1, and F4/80) in d4NA cells, d6NA cells, and BMM, respectively, was increased, whereas markers for B lymphocyte lineage cells (B220) and granulocyte lineage cells (Ly-6G) were decreased ( Table 1) . These surface marker data support the system as a model for macrophage differentiation. Also, phagocytosis of latex beads increased as maturation progressed, and the most active population was the BMM (data not shown). Thus, by several criteria, the system is a useful one to monitor a certain stage of CSF-1-induced macrophage differentiation.
Expression of cytoskeletal proteins during macrophage differentiation
The overall findings from a microarray analysis of our CSF-1-dependent macrophage differentiation system will be published elsewhere (manuscript in preparation). From this analysis, one of the "pathways" [32] that was commonly regulated at the gene expression level was the actin cytoskeleton. The regulation of this pathway is not surprising, as cytoskeletal restructuring is known to be required for processes such as cell adhesion and spreading, motility, and phagocytosis, which are important in the function of more mature macrophage-lineage cells [11, 33, 34] . One cytoskeletal protein whose gene showed the greatest relative expression in BMM was WAVE2, and interestingly, WAVE1 gene expression, relative to the value found in d4NA cells, was up-regulated threefold in d6NA cells but then restored in BMM to levels equivalent to that of d4NA cells. These microarray results were confirmed by qPCR ( Fig.  2A) and in the case of WAVE1, Northern blot analysis (Fig.  2C) . Expression of a third member of the WAVE family, 
Bone marrow cells were cultured in CSF-1 for 4 days in CSF-1 (Materials and Methods) and nonadherent cells (d4NA) harvested; the d4NA cells were then cultured for a further 2 days to give rise to nonadherent cells (d6NA) and adherent cells (BMM). The d4NA, d6NA, and BMM cells were labeled with antibodies to the respective surface markers for analysis by flow cytometry. Results are averaged from three experiments Ϯ SD. WAVE3, could not be detected by microarray or qPCR. In contrast to the regulation of WAVE2 and WAVE1 gene expression in our CSF-1-dependent system, that for proteins, which can associate with WAVE proteins in tissues and cells, namely Abelson interactor protein 1 (Abi1), Sra1, Nap1, and the Arp2/3 complex, did not vary (data not shown). Isoforms of myosin XVIIIA (Myo18A) have been described [24, 35] , and the p230 Myo18A variant 1 (MysPDZ␣) has been linked with macrophage maturation and adherence [24] . For these cytoskeletal protein isoforms, we also observed in the microarray analysis that their mRNA expression was regulated with a similar pattern to that for the WAVE isoforms, and the expression of the Myo18A variant 1 was greatest in BMM, and variant 2 (encoding the p190 ␤-isoform) was most highly expressed in d6NA. These expression data were confirmed by qPCR and Northern blot analysis, respectively (Fig. 2, B and C) .
When WAVE protein expression was measured, the levels of the 85-kDa WAVE2 and 80-kDa WAVE1 [20] correlated with those for their mRNA (Fig. 3A) . An additional, 60-kDa polypeptide was detected only in the BMM by the N-terminal WAVE1 antibody (Fig. 3A) but not by the C-terminal WAVE1 antibody (data not shown). Thus, for WAVE and Myo18A, the isoform expression is influenced by whether macrophages are an adherent population; the Myo18A system was not analyzed further (but see Discussion).
WAVE protein expression and macrophage adhesion
Given that expression of WAVE2 and WAVE1 are different in BMM and d6NA (Fig. 3A) , we sought to determine more directly whether these differences might involve cell adhesion. For this purpose, d6NA cells were cultured for a further 24 h in tissue-culture wells (in the presence of CSF-1) to allow adherence. At this time, almost all cells became adherent and were assessed for WAVE protein expression. As seen in Figure  3B , WAVE2 expression was induced, and full-length WAVE1 was down-regulated (approximately twofold), and the 60-kDa species appeared (lanes 1 vs. 2). Conversely, when BMM were cultured in reduced-adherent conditions, WAVE2 levels were slightly down-regulated (ϳ1.3-fold), and for WAVE1, the 60- kDa band disappeared, and there was a small increase in the levels of full-length protein ( ϳ1.2-fold; lanes 3 vs. 4 ). For the conditions under which there were clear adhesion-dependent differences in WAVE2 and full-length WAVE1 protein levels-when d6NA cells were adhered (Fig. 3B, lanes 1 and  2) -there were also clear and parallel differences in relative mRNA expression (Fig. 3C) . The data in Figure 3B suggest that in our CSF-1-induced macrophage differentiation system, the up-regulation of WAVE2 and also the down-regulation of fulllength WAVE1, as well as the emergence of the 60-kDa band (Fig. 3A) , are dependent, to some extent, on cell adhesion. They also help to explain why only WAVE2 has been observed previously in adherent macrophage populations [23, 36] (see Discussion).
Proteolytic degradation of WAVE1 in macrophages
We sought to obtain more evidence as to whether the 60-kDa band detected by the N-terminal WAVE1 antibody in BMM (Fig. 3) arises from the WAVE1 transcript and is unique to adherent macrophages. To this end, we transfected RAW264.7 cells, a macrophage cell line that adheres to tissue-culture plates, with a WAVE1-IRES-GFP construct. The expression of WAVE1 and GFP was detected by Western blot analysis and flow cytometry, respectively (Fig. 4, A and B) . We did not detect the 60-kDa band. However, it was observed that the full-length WAVE1, although detectable 24 h post-transfection, was absent at 48 h post-transfection (Fig. 4A ). This pattern is observed for cells cultured under adherent or reduced-adherent conditions, suggesting that the removal of fulllength WAVE1 in the RAW264.7 cells is probably not related to cell adhesion. The loss of WAVE1 could not be explained by the death of transfected cells, as GFP expression was similar at both time-points (Fig. 4B) . Another possibility is that WAVE1 was completely degraded by 48 h in the RAW264.7 cells as a result of its overexpression, potentially also explaining the absence of the 60-kDa polypeptide.
WAVE1 has been reported previously to be cleaved by the calcium-activated protease, calpain, with no cleavage products being reported [20] . We were therefore interested in whether calpain activity could explain the loss of full-length WAVE1 protein at 48 h post-transfection and the absence of the 60-kDa polypeptide in RAW264.7 cells. We investigated this possibility by overexpressing WAVE1 again in RAW264.7 cells but with a Myc-tagged construct, followed by the addition of calpeptin, a specific, cell-permeable calpain inhibitor [37] [38] [39] , at 24 h post-transfection. The expression of WAVE1 was analyzed at this time, as well as at 36 h and 48 h post-transfection in the absence or presence of calpeptin. Figure 5A shows that the 60-kDa polypeptide is detectable in RAW264.7 cells at 36 h after WAVE1 overexpression with its levels for the full-length protein also diminishing over time, and calpeptin delays the loss of full-length WAVE1 protein with concomitant changes in the levels of the 60-kDa polypeptide. These results suggest in this overexpression system that the 60-kDa polypeptide is a cleavage product of WAVE1 and that this cleavage is mediated by calpain.
We next examined whether a 60-kDa polypeptide could be generated by incubating WAVE1 with calpain in vitro.
As the N-terminal antibody to WAVE1 was not suitable for immunoprecipitation (data not shown), the C-terminal WAVE1 antibody was used, and the N-terminal antibody was used again for Western blotting. Anti-WAVE1 immunoprecipitates from BMM (Fig. 5B ) and d6NA cells (Fig. 5C ) displayed WAVE1 degradation upon exposure to calpain. From BMM, the main degradation product is a 60-kDa fragment, which increases in abundance with time over 1 h with concomitant reduction in levels of full-length WAVE1; however, for WAVE1 from d6NA cells, the degradation pattern is different from BMM in that there is not one major breakdown product but at least four, one of which is the 60-kDa fragment. With the exception of this 60-kDa fragment, the levels of these breakdown products also diminish over time in the presence of calpain. These data provide further evidence that WAVE1 is a proteolytic target of calpain with its cleavage generating a 60-kDa fragment.
Having established that calpain can proteolytically process WAVE1 over time into discernable fragments, we proceeded to examine the sites at which calpain may cleave WAVE1, as such fragmentation would likely affect WAVE1 function. We identified eight possible cleavage sites in the amino acid sequence of WAVE1 based on preferred motifs for calpain proteolysis [40] ; of these, two were likely candidates as a result of the expected size of the theoretically generated N-terminal peptides being 50 -70 kDa. Site-directed mutagenesis was then performed to mutate these two sites in WAVE1 at Pro-399 to Ala-403 and Pro-457 to Ser-460, respectively (Fig. 6A) . Figure 6B shows that although wild-type WAVE1 was degraded by calpain, the mutant WAVE1 form, in which the Pro-457 to Ser-460 site was altered, remained intact. The WAVE1 form mutated at site Pro-399 to Ala-403 showed a similar degradation pattern to the wild-type form (data not shown). These results suggest that the Pro-457 to Ser-460 site in WAVE1, which is N-terminal to the active VCA domain of WAVE1 [41] , is a target for calpain proteolysis.
Generation of a WAVE1 60-kDa polypeptide in BMM is calpain-dependent and calpainindependent
To ascertain whether endogenous WAVE1 levels in primary macrophages are altered by calcium influx and thus, in turn, by calpain activation, BMM were treated with the calcium ionophore, ionomycin. Following ionomycin treatment for 4 h at increasing concentrations, it was observed that the ratio of full-length WAVE1 at 80 kDa to the 60-kDa band was decreased from ϳ3:1 to 0.8:1 (Fig. 7A) . This effect of ionomycin was negated by pretreatment of the macrophages with calpeptin (Fig. 7B) . However, treatment of BMM with calpeptin alone did not inhibit the generation of the 60-kDa fragment; moreover, calpeptin did not alter the ratio between the two WAVE1 forms observed when the BMM were again cultured under adherent or reduced-adherent conditions (Fig. 7C) . Taken together, these data indicate that increased levels of calcium influx following ionomycin addition to BMM and thus, increased calpain activity can contribute significantly to the loss of full-length WAVE1 and to the concomitant generation of the 60-kDa anti-WAVE1 immunnoreactive protein. However, in the absence of ionomycin, calpain is unlikely to be responsible for the presence of the 60-kDa polypeptide in BMM.
We also examined whether WAVE2 protein expression is regulated by calcium influx and the associated calpain activity in BMM. Figure 7B shows that unlike those of WAVE1, the levels of WAVE2 protein do not change in the presence of ionomycin and/or calpeptin, suggesting that in contrast to WAVE1, in BMM, WAVE2 is unlikely to be a calpain substrate. 
DISCUSSION
In this paper, we established an in vitro system to examine CSF-1-dependent macrophage lineage differentiation beginning with a CSF-1R-enriched, nonadherent precursor population (d4NA cells) and then following changes over time and also upon adherence. It allows us to examine the influence of macrophage adherence on any cellular changes observed. This system is the first to show that WAVE1 and WAVE2 expression is regulated during the maturation of primary macrophages and by their adherence. As some macrophage functions, such as secretion, migration, and phagocytosis, require cytoskeletal remodeling [9 -11] , it was anticipated that the levels of WAVE1 and WAVE2 might be highest in the adherent macrophage population (i.e., BMM), notwithstanding the prior literature about the difficulty in detecting WAVE1 in macrophages [23] . Although WAVE2 levels followed the expected pattern, with BMM having the highest levels, surprisingly, this was not the case for WAVE1, whose expression, although increasing over time in nonadherent cells, decreased in BMM at the gene and protein level when compared with the levels in the d6NA cells. Additionally, BMM cultured under reducedadherent conditions up-regulated WAVE1 expression levels. Perhaps in the progression from d4NA toward d6NA cells, WAVE1 contributes to the alteration in cytoskeletal structures, such that nonadherent cells are able to become adherent, and is then removed. At the adherent-BMM stage, WAVE2 may then be required to contribute to the maintenance of these structures and participate, for example, in cell spreading and migration, as has indeed been shown for CSF-1-treated macrophages [23] . This reduction of WAVE1 in BMM and its restoration under reduced, adherent conditions illustrate the importance of considering the contribution of macrophage adherence to the expression of a particular macrophage product when trying to assess whether such a product is a feature of macrophage maturation/differentiation [16] .
The above findings help to explain those in a previous report showing that WAVE1 could not be detected in BMM, leading the authors to conclude first that WAVE2 appeared to be the only WAVE protein to be expressed at a significant level in macrophages and also second, that their data argue against the possibility that a small amount of WAVE1 is functionally relevant in macrophages [23] . Our findings now make it possible to compare the functions of these two WAVE proteins in macrophage populations, as we now know that adherence, presumably along with differentiation, contributes to the control of WAVE1 expression in our CSF-1-dependent system. A similar pattern of gene expression for Myo18A variant 1 (MysPDZ␣) and Myo18A variant 2 (MysPDZ␤) was noted in our differentiation system, and our data add to literature indicating increased expression of the former as macrophage lineage populations mature and adhere to a tissue-culture surface [24] . Different functions for these two Myo18A isoforms have been proposed [24] , and our dissociated gene expression data for these variants are in line with this possibility.
In BMM, in addition to reduced WAVE1 gene expression, we provided evidence for the first time for a 60-kDa form of WAVE1, which appeared to be generated from cleavage of full-length WAVE1 in intact BMM and in cell lysates. Although the 60-kDa polypeptide could be a product of a WAVE1 splice variant, Northern blot analysis suggested the existence of only one WAVE1 transcript in our macrophage lineage cultures (Fig. 2C) , and no other isoforms of WAVE1 have been reported previously. Although the antibody used above for Western blotting is directed against a region in the N-terminal WHD, the 60-kDa protein in BMM is unlikely to be WAVE2 or WAVE3, as their molecular weights are 85 kDa and 70 kDa, respectively [20] ; also, a similar species was noted when WAVE1 was overexpressed in RAW264.7 cells and when WAVE1 immunoprecipitates from BMM were incubated with calpain in vitro (see also Discussion below). The data suggest that in BMM, there are calpain-dependent and calpainindependent pathways for the cleavage of WAVE1, the former coming into play as intracellular Ca 2ϩ levels rise. Our data suggest that adhesion of primary macrophages can reduce WAVE1 expression by a calpain-independent cleavage but also at the level of mRNA expression. Thus, there would appear to be multiple mechanisms for regulating WAVE1 levels in macrophages. Whether the WAVE1 breakdown observed above has any relevance to the regulation of Ca 2ϩ signaling, for example, by adherence in macrophage lineage cells [16, [42] [43] [44] [45] [46] is unknown as is its relevance to the calpaindriven regulation of the motility of closely related cell types, namely dendritic cells and osteoclasts [39, 47] .
There were some differences in the pattern of WAVE1 degradation by calpain in the lysates from BMM and d6NA cells, perhaps indicating that WAVE1 is in different conformations or complexes within the two cell populations. That WAVE1 was not cleaved in vivo in d6NA cells could mean that it may have been protected from proteolysis by sequestration or localization. The studies above about the cleavage of mutated WAVE1 suggest that there is a calpain proteolytic site (Pro-457 to Ser-460) in WAVE1 in BMM located N-terminal to the VCA domain (see Fig. 6A ). The presence of proteolytic products other than the anticipated 60-kDa fragment suggests the existence of more than one calpain cleavage site in WAVE1 and that these sites are located in the VCA region of WAVE1, although the amino acid sequence Pro-457 to Ser-460 is required for proteolysis by calpain. It is possible that the Pro-457 to Ser-460 sequence acts as a recognition and/or binding site for calpain, such that regions C-terminal to this site are then also accessible for calpain cleavage.
Although further sequencing evidence is required, it appears that BMM adherence leads to a similar 60-kDa WAVE1 N-terminal fragment, which is not immunoprecipitated by the antibody to the C-terminal region of WAVE1 in BMM lysates (Fig. 5B) . It is possible that there is another protease(s), which is activated by macrophage adherence and with similar substrate specificity to calpain. Cleavage of WAVE to the 60-kDa fragment by adherence or calpain has possible functional implications, as the product generated would be the N-terminal fragment (ϳ60 kDa) consisting of the WHD domain, basic region, and the proline-rich region but lacking the VCA domain (see Fig. 6A ). As the VCA domain participates in actin polymerization by WAVE proteins [48] , dissociation of WAVE1 from this domain would lead to the inactivation of WAVE1.
WAVE2, in addition to having an opposite pattern of expression in our in vitro system to that for WAVE1, does not appear to be regulated by intracellular Ca 2ϩ levels or calpain activity, nor does it have an equivalent, putative calpain proteolytic site. This contrasting regulation of expression for the two WAVE isoforms suggests separate functions in macrophage biology. In this context, a WAVE2-Abi1 complex mediates CSF-1-induced, F-actin-rich protrusions and migration in BMM with no apparent role for WAVE1 in this response [23] . In general, differences in WAVE function are usually ascribed to differences in subcellular localization or relative affinities for specific proteins important for their regulation [23, 33] . Examples of differences in function in other cell types are that WAVE2 appears to be the stronger activator of the Arp2/3 complex [49] and that WAVE1 but not WAVE2 can induce cytoskeletal reorganization independently of Arp2/3 [50] . A similar situation may apply to Myo18A, whereas shown above and suggested before [24] , the presence of the PDZ-containing variant 1 seems to be related to the adherence and/or some other activities of mature macrophages. In this system, different cellular localizations have also been proposed to be a critical element in the separate functions of its isoforms [24] .
In summary, the establishment of the CSF-1-dependent differentiation system, by incorporating an emphasis on a possible contribution of adherence, has enabled us to demonstrate that WAVE1 may also be important to macrophage lineage function. In addition, we reported that WAVE1 and WAVE2 have contrasting patterns of expression in macrophage lineage populations, suggesting different functions. We were also able to provide evidence for a new 60-kDa cleavage product of WAVE1 in macrophage populations, which arises from calpain-dependent and calpain-independent pathways.
